EP300 and neoplasm: ,15 The functional interplay between KLF13 and p300/CBP via acetylation has been previously described,16 leading to our central hypothesis: that the tumor-specific expression of CES2 is controlled by a multi-layered cascade, initiated by p300-mediated acetylation of KLF13, which in turn transcriptionally activates CES2.